Welcome to our dedicated page for Cbd Life Science news (Ticker: CBDL), a resource for investors and traders seeking the latest updates and insights on Cbd Life Science stock.
CBD Life Sciences Inc. (CBDL) is a publicly traded wellness company active in the CBD, hemp, cannabis, functional mushroom, and nutraceutical sectors through its flagship brand The CBD Vault. The CBDL news feed on Stock Titan aggregates company-issued updates and announcements that describe how the business is expanding its product portfolio and distribution footprint.
In its recent news, CBD Life Sciences highlights agreements with dispensaries, luxury spas, and wellness retailers, including partnerships with Smoking Scholars in the Bronx, Red Hots Spa locations in New York, and Mother Earth Juice Bar at John F. Kennedy International Airport. These items outline how CBDL places CBD topicals, infused beverages, hemp-derived pain creams, and other wellness products into high-traffic consumer environments.
Press releases also cover product launches such as anti-inflammatory gels, CBD beverages, functional mushroom offerings, and plant-based energy and diet gummies. The company’s communications describe participation in cannabis conferences, Letters of Intent with dispensaries, and efforts to grow wholesale and retail channels in markets like New York and New Jersey.
Investors and followers can use this news page to review CBDL’s own descriptions of its partnerships, product introductions, and channel development over time. By reading these updates together, readers can see how CBD Life Sciences Inc. presents its strategy in CBD wellness, cannabis-related products, functional beverages, and mushroom-based formulations under The CBD Vault brand.
CBD Life Sciences (OTC:CBDL) announced Smoking Scholars, a Bronx dispensary, expanded its relationship to become a major distributor of CBDL's Dubai Mushroom Chocolate on February 3, 2026. The move follows strong in-store performance of existing CBDL products and targets high-traffic urban retail to drive repeat sales and retail velocity.
Management says the placement offers immediate revenue opportunity and a scalable blueprint for further dispensary expansion across New York and other metropolitan markets.
CBD Life Sciences (OTC:CBDL) announced a retail partnership placing its 8000MG Hemp Pain Relief Cream with Mother Earth Juice Bar, including a high-visibility storefront inside JFK Airport, Terminal 8 near Gate 39 in Queens, New York, effective January 6, 2026.
This placement targets millions of domestic and international travelers annually and aims to boost brand exposure across travel, hospitality, and national wellness retail channels. Management says the placement validates product quality and supports plans for additional retail expansion.
CBD Life Sciences (OTC:CBDL) CEO Lisa Nelson appeared on The Morning Show on December 2, 2025 to discuss the company's rapid expansion across multiple wellness verticals. Highlights include category expansion into topicals, edibles, functional water, nutraceutical powders and veterinarian products, plus a Walmart Marketplace approval for the 3000mg Pain Cream. The release cites a $14.6B 2025 CBD market value and a projection to $203.4B by 2034. Management points to four‑digit year‑over‑year revenue growth since early 2024 and retail, spa, and e‑commerce distribution efforts as drivers of near‑term scaling potential.
CBD Life Sciences (OTC:CBDL) announced on November 18, 2025 the launch of its Tremendous Anti-Inflammatory Soothe Gel at two Red Hots Spa locations in New York: Garden City Hotel (Garden City) and Roslyn.
The topical formula lists menthol, camphor, and capsaicin as active ingredients and is described as engineered for immediate cooling relief and deep tissue penetration. CBDL positions the rollout as an East Coast retail expansion that expands The CBD Vault's physical footprint and wholesale catalog while targeting the luxury spa wellness market.
CBD Life Sciences (OTC Pink: CBDL) announced a repeat bulk order from Bronx dispensary Smoking Scholars on November 12, 2025, supplying three premium hemp flower strains from its branded unit The CBD Vault: Hawaii Haze (hybrid), Jet Fuel (sativa) and Purple Gas (indica).
The release highlights a 1405.46% revenue increase since February 2024 and positions CBDL to expand distribution in New York’s cannabis market, which the release cites as projected to reach $7.2B by 2030. The company frames the order as evidence of recurring wholesale demand and growing retail placement momentum.
CBD Life Sciences (OTC: CBDL) launched two hemp-free, vegan gummies on October 28, 2025: Energy Boost Gummies (100 mg) and Diet & Weight-Loss Gummies (100 mg). Both formulas use plant-based ingredients—Energy: green tea extract, caffeine, BCAA, L-Arginine; Diet: maca, caffeine, yohimbe, guarana, bitter orange.
The company cites a growing gummy supplements market projected to exceed $50 billion by 2030, positioning these SKUs to expand distribution into fitness, nutrition, pharmacy, and e-commerce channels and to diversify revenue beyond CBD products.
CBD Life Sciences (OTC PINK:CBDL) announced the launch of a Mushroom-Infused Dubai Chocolate Bar through its subsidiary CBD Vault on October 21, 2025. The premium bar blends pistachio-filled Dubai-style chocolate with Cordyceps and Reishi extracts, positioning the company at the intersection of luxury confectionery and functional wellness.
The release cites the Dubai chocolate market > $1.5 billion with a 6.8% annual growth rate and a projected $35 billion global functional mushroom market by 2030 (CAGR 10.8%). CBDL says it will add the product to its Mushroom Madness line and pursue international and domestic distribution, expecting recurring revenue in Q4 2025 and through 2026.
CBD Life Sciences (OTC:CBDL) announced a major retail expansion after a large order from Smoking Scholars dispensary in the Bronx on October 14, 2025. CBDL's top-selling beverages — 16oz 50mg CBD Lemonade, 16oz 25mg CBD Raspberry Lemonade, 16oz 25mg CBD Lavender Lemonade, and CBD-infused water — will appear on Smoking Scholars' shelves, supporting the company’s East Coast retail push.
The company cites strong consumer demand, NECANN conference leads, and a growing regional pipeline across New Jersey and Pennsylvania, with management projecting recurring bulk orders and potential six-figure monthly sales as additional dispensaries onboard.
CBD Life Sciences (OTC:CBDL) has secured a strategic partnership with Smoking Scholars, a premier Bronx dispensary, marking a significant expansion into the New York cannabis market. The agreement includes an initial order of various CBD products including pain relief cream, massage oil, gummies, tea, and mushroom face cream.
The partnership emerged following CBDL's successful showcase at the NECANN New Jersey Conference and is expected to generate hundreds of thousands in revenue within 12 months. This move positions CBDL strategically in the New York market, where dispensary sales are projected to reach $4.4 billion by 2027. The company is actively pursuing additional partnerships across the Northeast region.
CBD Life Sciences (OTC:CBDL) has signed a Letter of Intent (LOI) with a licensed New Jersey dispensary, marking a strategic entry into the East Coast cannabis market. The partnership establishes a unique dual-channel distribution model where CBD Vault's products will be featured in the New Jersey dispensary while the dispensary's products will be sold in CBDL's retail locations.
The company expects this partnership to generate seven-figure annual revenues and serve as a springboard for expansion in the East Coast corridor. The New Jersey cannabis market alone is projected to exceed $2 billion annually by 2026, while the broader U.S. CBD and cannabis sector is forecasted to reach $33 billion by 2030.
FAQ
What is the current stock price of Cbd Life Science (CBDL)?
What is the market cap of Cbd Life Science (CBDL)?
